Skip to content
August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press a-new-era-for-genomic-science-ashg-announces-strategic-publishing-partnership-with-oxford-university-press
  • Genomics and Precision Medicine

A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press

Muslim August 6, 2026
ROCKVILLE, MD – In a move poised to reshape the dissemination of global genomic research, the American...
Read More Read more about A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press
Beyond the Checkbook: The Strategic Power of Gifts-in-Kind in Modern Philanthropy beyond-the-checkbook-the-strategic-power-of-gifts-in-kind-in-modern-philanthropy
  • Survivorship and Post-Treatment

Beyond the Checkbook: The Strategic Power of Gifts-in-Kind in Modern Philanthropy

Pevita Pearce August 6, 2026
By Madison Decker, Charitable Advancement Manager, National Breast Cancer Foundation (NBCF) When corporate leaders envision their philanthropic...
Read More Read more about Beyond the Checkbook: The Strategic Power of Gifts-in-Kind in Modern Philanthropy
What is ‘Premium Content’ on Clinical Trials Arena? what-is-premium-content-on-clinical-trials-arena
  • Medical Research and Clinical Trials

What is ‘Premium Content’ on Clinical Trials Arena?

Azzam Bilal Chamdy August 6, 2026
London, UK – [Date of Publication] – Clinical Trials Arena, a leading digital publication dedicated to the...
Read More Read more about What is ‘Premium Content’ on Clinical Trials Arena?
Pharma’s Mid-Year Reckoning: Gilead, Pfizer, and Merck Navigate a High-Stakes Earnings Season pharmas-mid-year-reckoning-gilead-pfizer-and-merck-navigate-a-high-stakes-earnings-season
  • Treatment Innovations

Pharma’s Mid-Year Reckoning: Gilead, Pfizer, and Merck Navigate a High-Stakes Earnings Season

Nila Kartika Wati August 6, 2026
As the second quarter of 2026 draws to a close, the pharmaceutical industry finds itself at a...
Read More Read more about Pharma’s Mid-Year Reckoning: Gilead, Pfizer, and Merck Navigate a High-Stakes Earnings Season
Redefining the Standard of Care: Insights from the EMBARK Trial in High-Risk Prostate Cancer redefining-the-standard-of-care-insights-from-the-embark-trial-in-high-risk-prostate-cancer
  • Clinical Oncology Education

Redefining the Standard of Care: Insights from the EMBARK Trial in High-Risk Prostate Cancer

Rifan Muazin August 6, 2026
The landscape of prostate cancer treatment has undergone a significant transformation over the past decade, driven by...
Read More Read more about Redefining the Standard of Care: Insights from the EMBARK Trial in High-Risk Prostate Cancer
Beyond the Diagnosis: The Psychological and Spiritual Evolution of a Cancer Survivor beyond-the-diagnosis-the-psychological-and-spiritual-evolution-of-a-cancer-survivor
  • Survivorship and Post-Treatment

Beyond the Diagnosis: The Psychological and Spiritual Evolution of a Cancer Survivor

Evan Lee Salim August 6, 2026
Introduction: The Anatomy of Resilience Cancer is often described in the language of war—a battlefield of cells,...
Read More Read more about Beyond the Diagnosis: The Psychological and Spiritual Evolution of a Cancer Survivor
Beyond the AI Hype: Why Verseon Is Betting on Physics-First Drug Discovery beyond-the-ai-hype-why-verseon-is-betting-on-physics-first-drug-discovery
  • Chemotherapy and Targeted Therapy

Beyond the AI Hype: Why Verseon Is Betting on Physics-First Drug Discovery

Layla Zulfa August 6, 2026
In the rapidly evolving landscape of modern pharmacology, the narrative has been dominated by the meteoric rise...
Read More Read more about Beyond the AI Hype: Why Verseon Is Betting on Physics-First Drug Discovery
The High-Stakes Duel: Novo Nordisk and Eli Lilly Navigate a Volatile Obesity Drug Market the-high-stakes-duel-novo-nordisk-and-eli-lilly-navigate-a-volatile-obesity-drug-market
  • Chemotherapy and Targeted Therapy

The High-Stakes Duel: Novo Nordisk and Eli Lilly Navigate a Volatile Obesity Drug Market

Siti Muinah August 5, 2026
The global pharmaceutical landscape is currently defined by a high-stakes, multi-billion-dollar race to dominate the obesity medication...
Read More Read more about The High-Stakes Duel: Novo Nordisk and Eli Lilly Navigate a Volatile Obesity Drug Market
The Viral Stretch: Deconstructing the 103-Million-View Yoga Phenomenon the-viral-stretch-deconstructing-the-103-million-view-yoga-phenomenon
  • Integrative Oncology and Holistic Care

The Viral Stretch: Deconstructing the 103-Million-View Yoga Phenomenon

Asep Darmawan August 5, 2026
In the age of algorithmic curation, viral success is rarely accidental. While social media feeds are often...
Read More Read more about The Viral Stretch: Deconstructing the 103-Million-View Yoga Phenomenon
A New Era in Ovarian Cancer Treatment: King’s College London Unveils Groundbreaking IgE Antibody Therapy a-new-era-in-ovarian-cancer-treatment-kings-college-london-unveils-groundbreaking-ige-antibody-therapy
  • Medical Research and Clinical Trials

A New Era in Ovarian Cancer Treatment: King’s College London Unveils Groundbreaking IgE Antibody Therapy

Muslim August 5, 2026
LONDON, UK – In a significant leap forward for cancer immunotherapy, researchers at King’s College London have...
Read More Read more about A New Era in Ovarian Cancer Treatment: King’s College London Unveils Groundbreaking IgE Antibody Therapy

Posts pagination

Previous 1 … 11 12 13 14 15 16 17 … 417 Next

Recent Posts

  • The Dismantling of U.S. Global Health: An Analysis of the Post-2025 Foreign Assistance Overhaul
  • AI-Powered Mammograms Uncover Hidden Heart Risks, Revolutionizing Women’s Health Screening
  • Kardium’s Globe Pulsed Field System Gains Health Canada Approval: A New Era for Atrial Fibrillation Treatment
  • Navigating Chemotherapy-Induced Hair Loss: A Comprehensive Guide to Wigs and Support
  • PepGen’s PGN-EDODM1 Advances to Highest Dose in Phase II DM1 Trial Amidst Strong Safety Profile

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-dismantling-of-u-s-global-health-an-analysis-of-the-post-2025-foreign-assistance-overhaul
  • Breast Cancer Legislation and Policy

The Dismantling of U.S. Global Health: An Analysis of the Post-2025 Foreign Assistance Overhaul

Nila Kartika Wati August 8, 2026
ai-powered-mammograms-uncover-hidden-heart-risks-revolutionizing-womens-health-screening
  • Medical Research and Clinical Trials

AI-Powered Mammograms Uncover Hidden Heart Risks, Revolutionizing Women’s Health Screening

Asep Darmawan August 8, 2026
kardiums-globe-pulsed-field-system-gains-health-canada-approval-a-new-era-for-atrial-fibrillation-treatment
  • Treatment Innovations

Kardium’s Globe Pulsed Field System Gains Health Canada Approval: A New Era for Atrial Fibrillation Treatment

Rifan Muazin August 8, 2026
navigating-chemotherapy-induced-hair-loss-a-comprehensive-guide-to-wigs-and-support
  • Patient Advocacy and Support

Navigating Chemotherapy-Induced Hair Loss: A Comprehensive Guide to Wigs and Support

Muslim August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.